Access cutting-edge prostate cancer treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
The primary objective is to assess the activity and efficacy of pembrolizumab, a checkpoint inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficiency (dMMR) or biallelic inactivation of CDK12 (CDK12-/-). The secondary objectives involve determining the frequency with which dMMR and CDK12-/- occur in this patient population, as well as the effects of pembrolizumab on various clinical endpoints (time to PSA progression, m
Sponsor: VA Office of Research and Development
Check if you qualify for this prostate cancer clinical trial in San Francisco, CA
If you're searching for prostate cancer treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.